The milestone reflects KFSH’s ongoing efforts to advance its gene therapy program, bridging clinical care with translational research. By leveraging patient-specific genetic profiles, the hospital is ...

Modifying hematopoietic stem cells to correct the underlying genetic defect, followed by reinfusion of the modified cells ...

Chronic kidney disease (CKD) is a public health challenge that affects more than 800 million people worldwide. 1 CKD can be caused by a variety of disease processes. Many causes are difficult to ...

Researchers identified biallelic variants in RNU2-2 as the cause of a recessive neurodevelopmental disorder marked by ...

A new study has answered a question that has puzzled cancer researchers for decades: Does a genetic defect found in nearly ...

New research from Queen Mary University of London (QMUL) has identified a novel syndrome in patients with kidney and adrenal disease. The research, published in the Journal of Clinical Investigation, ...

Project MinE, an international consortium co-founded by researchers at King's College London, has identified new genetic ...

Scientists at Sanford Burnham Prebys Medical Discovery Institute and an international team of collaborators have defined a ...

Genetic defects are exceedingly common, which is not surprising considering just how many cells make up our bodies, including our reproductive cells. While most of these defects have no or only minor ...

Gene therapy is a revolutionary field in modern medicine, offering transformative potential to treat and potentially cure a wide range of genetic and acquired diseases. By addressing the root cause of ...